The McMaster Toronto Arthritis patient preference questionnaire (MACTAR): a methodological study of reliability and minimal detectable change after a 6 week-period of acupuncture treatment in patients with rheumatoid arthritis

Table 1 Demographic data of the eight participants with RA and individual pre- and post-acupuncture self-reported assessments

ID	Gender	Age, years	RA duration, years	Living situation	Work/sick leave	Medication	MACTAR median 1 and 2, A-phase		MACTAR		VAS pain, 0–100		VAS, 0–100 Well-being
ID	Gender	Age, years	RA duration, years	Living situation	Work/sick leave	Medication	A1	A2	B1	B10	B1	B10	B1	B10
1	F	68	2	Living with partner	Retired	Cox^a, Dmard^b	45	43	43	41	69	75	76	70
2	M	56	1.5	Living with partner	Work 20%	Dmard^b	54	54	54	60	43	49	43	42
3	F	63	10	Living alone	Sick-leave 100%	Dmard^b, TNF^c, kortison^d	52	52	55	65	29	10	30	15
4	F	57	2.5	Living with partner	Work 100%	Dmard^b	55	56	56	47	38	57	17	60
5	F	54	6	Living alone	Work 50%	Dmard^b	40	52	56	62	49	50	34	51
6	M	65	24	Living with partner	Work 75%	Cox^a, Dmard^b	54	55	55	63	18	9	17	10
7	M	63	30	Living with partner	Sick-leave 100%	Cox^a, TNF^c	54	52	50	56	8	10	16	11
8	F	30	20	Living with partner	Work 50%	Cox^a	44	43	44	65	62	42	71	35

B1 first assessment during the B-phase, B10 last assessment in the B-phase after 10 acupuncture treatments
^aCyclooxygenase inhibitor (COX-inhibitor)
²Disease modifying anti rheumatic drugs (DMARD)
³Tumor necrosis factor (TNF-inhibitor)
⁴Glucocorticoids (prednisolone)

ISSN: 1756-0500